Association of Acute Endophthalmitis With Intravitreal Injections of Corticosteroids or Anti–Vascular Growth Factor Agents in a Nationwide Study in France-Reference-Cited by-同舟云学术

Association of Acute Endophthalmitis With Intravitreal Injections of Corticosteroids or Anti–Vascular Growth Factor Agents in a Nationwide Study in France

Published:2018-12-01 Issue:12 Volume:136 Page:1352
ISSN:2168-6165
Container-title:JAMA Ophthalmology
language:en
Short-container-title:JAMA Ophthalmol

Author:

Baudin Florian¹,Benzenine Eric²,Mariet Anne-Sophie²³⁴⁵,Bron Alain M.¹⁶,Daien Vincent⁷⁸,Korobelnik Jean François⁹¹⁰,Quantin Catherine²³⁴⁵,Creuzot-Garcher Catherine¹⁶

Affiliation:

1. Department of Ophthalmology, Dijon University Hospital, Dijon, France

2. Department of Biostatistics and Bioinformatics, Dijon University Hospital, Franche-Comté University, Dijon, France

3. Institut National de la Santé et de la Recherche Medicale (INSERM), Centre d’Investigation Clinique 1432, Dijon, France

4. Clinical Investigation Center, Clinical Epidemiology/Clinical Trials Unit, Dijon University Hospital, Dijon, France

5. Department of Biostatistics, Biomathematics, Pharmacoepidemiology and Infectious Diseases, INSERM, Université de Versailles Saint-Quentin-en-Yvelines, Institut Pasteur, Université Paris-Saclay, Paris, France

6. Eye and Nutrition Research Group, Bourgogne Franche-Comté University, Dijon, France

7. Department of Ophthalmology, University Hospital of Montpellier, Montpellier, France

8. INSERM U1061, University of Montpellier, Montpellier, France

9. Department of Ophthalmology, University Hospital of Bordeaux, Bordeaux, France

10. INSERM U1219, Population Health Research Center, Bordeaux, France

Publisher

American Medical Association (AMA)

Subject

Ophthalmology

Reference43 articles.

1. Anti–vascular endothelial growth factor pharmacotherapy for age-related macular degeneration: a report by the American Academy of Ophthalmology.;Ip;Ophthalmology,2008

2. Five-year outcomes with anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration: the Comparison of Age-Related Macular Degeneration Treatments trials.;Maguire;Ophthalmology,2016